C

Cencora

Distributes medicines and supports patient care

M365 Operations Manager

Full-TimeUpdated on 10/15/2026
€5.9k - €8.1k/mo+ Annual bonus
Senior
Bachelor's
Vilnius, Vilnius City Municipality, Lithuania
In Person
IT OperationsEnterprise Applications

About the job

Requirements
  • A Bachelor's degree in Computer Science, Information Systems, Business Administration, or a related field, or equivalent work experience.
  • Typically 5 to 7 years of IT operations, systems administration, or enterprise collaboration services experience, including experience leading teams or operational support functions.
  • Experience managing teams, leading operational support functions, and building relationships across technical, business, and leadership levels.
  • Demonstrated ability to launch and deliver IT projects, operational initiatives, or service improvement efforts on time and within budget.
  • Technical aptitude comparable to a Principal or Level III engineer, including the ability to learn, evaluate, and operationalize new Microsoft 365 technologies.
  • Working knowledge of Microsoft 365 administration, including Exchange Online, Microsoft Teams, SharePoint Online, OneDrive, Intune, Entra ID, multifactor authentication, and related security and compliance concepts.
  • Familiarity with ServiceNow and administrative dashboards, service health tools, and Microsoft 365 reporting capabilities.
  • Ability to triage and troubleshoot issues escalated by the operations team, Service Desk, IT partners, business stakeholders, and other sources.
  • Experience supporting Microsoft 365 migrations, integrations, lifecycle activities, tenant standardization, and workload rationalization, including cloud-to-cloud and acquisition or divestiture scenarios.
  • Ability to build dashboards and reports covering service health, support volume, adoption, compliance readiness, and operational performance.
  • Understanding of Microsoft 365 governance, lifecycle management, access controls, licensing considerations, and enterprise compliance obligations.
  • Experience identifying opportunities for automation, AI-assisted operations, process improvement, and reducing manual administrative work.
  • Familiarity with enterprise identity and access systems, including Active Directory, Entra ID, multifactor authentication, privileged access processes, and related support practices.
Responsibilities
  • Own the Microsoft 365 collaboration and productivity experience across business units, including incident, request, problem, change, and escalation management for supported services.
  • Lead system administrators supporting the evolving Microsoft 365 environment, including recurring mergers and acquisitions integrations, tenant growth, standardization, and operational change.
  • Build and maintain dashboards monitoring service health, support trends, adoption, operational performance, and project readiness.
  • Manage Microsoft 365 migration, integration, lifecycle, and standardization efforts in line with business priorities, timelines, and operational readiness needs.
  • Define, document, and maintain Microsoft 365 administration standards, support processes, governance controls, and operational runbooks.
  • Support Microsoft 365 governance activities, including policy standardization, lifecycle management, access controls, compliance alignment, and coordination with Information Security, Legal, and Records/Retention stakeholders.
  • Identify and implement automation in ServiceNow, Microsoft 365 administration, reporting, and request fulfillment to reduce manual work and improve the associate experience.
  • Support budget planning and cost management for Microsoft 365 services, licensing, vendors, and operational improvements.
  • Identify opportunities to improve service value and reduce unnecessary costs.
  • Direct the development and implementation of technologies and processes that improve associate productivity, simplify Microsoft 365 administration, increase operational efficiency, and enhance collaboration-service reliability.
  • Evaluate automation, analytics, and AI-assisted operations to improve service delivery, reporting, request fulfillment, and issue resolution.
  • Monitor service performance, support trends, and escalation activity against defined operational expectations.
  • Use service-level agreement and service-health data to identify improvements, reduce recurring issues, and improve the associate experience.
  • Support vendor decisions, including Microsoft escalations, licensing impacts, contract input, and service-performance discussions for Microsoft 365 and related collaboration services.
  • Review Microsoft and third-party provider performance, support quality, roadmap alignment, and operational impacts.
  • Identify and confirm vendor performance problems, coordinate escalations, and notify contract managers or vendor owners as appropriate.
  • Set team priorities and measurable goals.
  • Coach and develop administrators.
  • Support performance management, skill growth, knowledge sharing, and succession readiness.
  • Plan and communicate operational changes related to Microsoft 365 integrations, standardization, governance changes, and service improvements.
  • Reduce disruption through stakeholder communication, readiness planning, and support preparation.
Desired Qualifications
  • Experience in a large enterprise Microsoft 365 environment, including operational support, governance, reporting, automation, migration, and stakeholder management responsibilities.

About the company

Cencora buys and distributes medicines for pharmacies, hospitals and physician practices, while helping drug manufacturers bring treatments to patients. Its businesses combine wholesale supply networks with specialty distribution for complex therapies and services that support prescribing and patient access. Customers order medicines through its distribution systems, and its teams manage sourcing, storage and delivery alongside pharmacy operations and manufacturer support. It earns revenue from pharmaceutical sales and fees for logistics and healthcare services. The parent company was formed in 2001 through the merger that created AmerisourceBergen, adopted the Cencora name in 2023, and is headquartered in Conshohocken, Pennsylvania.

Company Size

10,001+

Company Stage

IPO

Headquarters

Conshohocken, Pennsylvania

Founded

2001

Get referred to Cencora

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Pharmacy contracts deepen customer ties: Cencora negotiates insurer agreements and handles administrative work through its managed-care networks.
  • Eligible US staff gain retirement support: Cencora counts student-loan payments toward its employer match, up to 4% of pay.
  • Drug demand expands sales: Cencora reported 5.1% quarterly revenue growth in August 2026, led by higher US volumes.

What critics are saying

  • Customer dependence concentrates risk: Walgreens and Boots supplied 25% of Cencora's fiscal 2025 revenue, reported in November 2025.
  • Legal liabilities tie up cash: Cencora's November 2025 filing recorded $4.3 billion in opioid settlements, payable over 13 years.
  • Warehouse work is physical: Cencora's day-shift associate listing requires repeated lifting up to 50 pounds and overtime availability.

What makes Cencora unique

  • Independent pharmacies get a shared brand: Cencora's Good Neighbor Pharmacy franchise supports their merchandising and store identity.
  • Specialty shipments use reusable packaging: Cencora's World Courier Cocoon containers combine passive temperature control with live location monitoring.
  • Medicines arrive ready for bedside checks: Cencora's American Health Packaging sells barcoded unit doses that support hospital scanning.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Parental Leave

Adoption Assistance

Infertility Coverage

Family Planning Benefits

Behavioral Health Solutions

Professional Development Budget

Training Programs

Company News

Associated Press
Sep 2nd, 2026
Cencora launches cell and gene therapy service to help health systems scale advanced treatment programmes

Cencora has launched Cell and Gene Therapy Enablement through its Accelerate Pharmacy Solutions division to help health systems develop and expand cell and gene therapy programmes. The service provides support across financial planning, operational readiness, and scalable growth to reduce care barriers and improve patient access to advanced therapies. More than 35 cell and gene therapies have received FDA approval, with over 1,700 clinical trials underway globally. However, only 4% of health system pharmacy leaders report being fully prepared to integrate these treatments, highlighting infrastructure gaps. The offering includes market assessments, readiness evaluations, governance design, and workflow planning. Cencora, ranked number 10 on the Fortune 500 with over $300 billion in annual revenue, already provides specialty pharmaceutical services across the therapy lifecycle.

Yahoo Finance
Aug 14th, 2026
Cencora beats Q2 profit estimates as specialty pharma platform drives growth

Cencora reported second-quarter revenue of $84.75 billion, slightly above analyst estimates of $84.43 billion, representing 5.1% year-on-year growth. Adjusted earnings per share came in at $4.48, beating consensus estimates of $4.35 by 3%. Management attributed the performance to strength in specialty pharmaceuticals, particularly through Management Services Organisations like OneOncology and RCA. CEO Robert Mauch highlighted the company's positioning in specialty care, stating, "Our specialty platform supports growth across the healthcare ecosystem." The company raised its full-year adjusted EPS guidance to $17.85 at the midpoint. Operating margin held steady at 1.3%, matching the same quarter last year. During the earnings call, analysts questioned management about biosimilar opportunities, specialty logistics competition, and potential policy risks from proposed ASP rule changes.

Yahoo Finance
Aug 12th, 2026
Cencora raises FY2026 guidance after Q3 EPS jumps 12%, buys back $1B in shares

Cencora reported strong third-quarter results for fiscal year 2026, driven by execution across its business units and investments in its specialty positioning. The pharmaceutical distributor achieved double-digit adjusted operating income growth and 12% earnings per share growth in the quarter. The company conducted $1 billion in opportunistic share repurchases during the period. Based on its performance and confidence in continued execution, Cencora raised its fiscal 2026 EPS guidance. President and CEO Robert Mauch credited the results to the company's team members and their commitment to providing solutions for customers. He highlighted the strength of Cencora's portfolio and its pharmaceutical-centric strategy as the company approaches the end of its fiscal year. The earnings call was held on 5 August 2026, with senior leadership including Mauch and CFO Eva Boratto participating.

MarketScreener
Aug 5th, 2026
Cencora boosts credit facility to $7B, extends maturity to 2031

Cencora and its subsidiary Innomar Strategies have amended their credit agreement, increasing their multi-currency revolving credit facility from $5.5 billion to $7.0 billion. The facility's maturity date has been extended to July 2031. Interest rates on borrowings range from 69.5 to 110 basis points over various term rates, depending on Cencora's public debt ratings. The agreement includes covenants such as a maximum financial leverage ratio. Separately, on 31 July 2026, Cencora amended its receivables securitisation facility, reducing it from $1.5 billion to $1.0 billion whilst increasing the accordion feature from $500 million to $1.0 billion. This gives the company the option to expand commitments by up to $1.0 billion, subject to bank approval.

Yahoo Finance
Aug 1st, 2026
Cencora Q3 earnings preview: analysts expect $4.37 EPS on $84.89B revenue

Wall Street analysts expect Cencora to report quarterly earnings of $4.37 per share, marking a 9.3% year-over-year increase. Revenues are projected to reach $84.89 billion, up 5.2% from the same quarter last year. Over the past 30 days, the consensus earnings per share estimate has been revised upward by 1.3%. Analysts forecast revenue from Total US Healthcare Solutions at $75 billion, representing 2.9% year-over-year growth. International Healthcare Solutions revenue is expected to remain flat at $7.79 billion. Operating income projections show US Healthcare Solutions at $940.87 million and International Healthcare Solutions at $158.45 million. Cencora shares have risen 5.3% over the past month and hold a Zacks Rank of 2, indicating expected outperformance versus the broader market.